📑P.A.S. 2023-5-50. Suministro de viales esteriles en sistema cerrado para preparacion de alicuotas de PRP y suero autologo
Procurement process summary
This process is to purchase P.A.S. 2023-5-50. Suministro de viales esteriles en sistema cerrado para preparacion de alicuotas de PRP y suero autologo.
This contract was awarded by 🇪🇸 Hospital Universitario La Paz for an amount of EUR 60,960 to 1 supplier. It was published on 2023-12-15 through limited
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇪🇸 Hospital Universitario La Paz Buying unitnot reported Publication date2023-12-15 Contest statusnot reported Descriptionnot reportedAwards
This award was granted to PRÓTESIS HOSPITALARIAS, S.A. by Hospital Universitario La Paz for an amount of EUR 60,960. The procurement process was conducted through limited for the category of goods. This is award number 1.
| Supplier | Amount | Award number |
|---|---|---|
| 🇪🇸 PRÓTESIS HOSPITALARIAS, S.A. | EUR 60,960 | 1 |
Market context and opportunities
The execution of this contract allows the entity Hospital Universitario La Paz to fulfill its public service objectives efficiently.
The limited purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberES_ocds-70d2nz-012a8db7-dd21-4dcf-ad80-64b826c8a3fa-award-1Publication date2023-12-15Contract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalitylimitedMethod details9Statusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
